Stock ORIAU ORION BIOTECH OPPORTUNITIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Orion Biotech Opportunities Corp. OTC Markets

Equities

ORIAU

KYG6780C1252

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Orion Biotech Opportunities Corp.(OTCPK:ORIA) dropped from NASDAQ Composite Index
CI
Orion Biotech Opportunities : will redeem its Public Shares and will not consummate an initial business combination - Form 8-K
PU
ORION BIOTECH OPPORTUNITIES CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
Orion Biotech Opportunities Corp. Auditor Raises 'Going Concern' Doubt
CI
Orion Biotech Opportunities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Orion Biotech Opportunities Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Orion Biotech Opportunities Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
Orion Biotech Opportunities Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021
CI
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
AQ
ORION BIOTECH OPPORTUNITIES CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Certain Class B Ordinary Shares of Orion Biotech Opportunities Corp. are subject to a Lock-Up Agreement Ending on 9-NOV-2021.
CI
ORION BIOTECH OPPORTUNITIES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Orion Biotech Opportunities Corp. has completed an IPO in the amount of $200 million.
CI
Orion Biotech Opportunities Corp. has filed an IPO in the amount of $200 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORIA Stock
  4. ORIAU Stock
  5. News Orion Biotech Opportunities Corp.